ABCL
Price
$5.63
Change
-$0.10 (-1.74%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
1.72B
44 days until earnings call
Intraday BUY SELL Signals
LGND
Price
$279.27
Change
+$17.10 (+6.52%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
5.6B
49 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABCL vs LGND

ABCL vs LGND Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABCL vs. LGND commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and LGND is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (ABCL: $5.74 vs. LGND: $262.10)
Brand notoriety: ABCL and LGND are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 68% vs. LGND: 352%
Market capitalization -- ABCL: $1.75B vs. LGND: $5.6B
ABCL [@Biotechnology] is valued at $1.75B. LGND’s [@Biotechnology] market capitalization is $5.6B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileLGND’s FA Score has 1 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • LGND’s FA Score: 1 green, 4 red.
According to our system of comparison, LGND is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 5 TA indicator(s) are bullish while LGND’s TA Score has 5 bullish TA indicator(s).

  • ABCL’s TA Score: 5 bullish, 3 bearish.
  • LGND’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than LGND.

Price Growth

ABCL (@Biotechnology) experienced а +9.13% price change this week, while LGND (@Biotechnology) price change was +3.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 06, 2026.

LGND is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LGND($5.6B) has a higher market cap than ABCL($1.72B). ABCL YTD gains are higher at: 67.836 vs. LGND (38.623). LGND has higher annual earnings (EBITDA): 224M vs. ABCL (-167.02M). LGND has more cash in the bank: 792M vs. ABCL (505M). ABCL has less debt than LGND: ABCL (140M) vs LGND (452M). LGND has higher revenues than ABCL: LGND (274M) vs ABCL (79.2M).
ABCLLGNDABCL / LGND
Capitalization1.72B5.6B31%
EBITDA-167.02M224M-75%
Gain YTD67.83638.623176%
P/E RatioN/A34.18-
Revenue79.2M274M29%
Total Cash505M792M64%
Total Debt140M452M31%
FUNDAMENTALS RATINGS
LGND: Fundamental Ratings
LGND
OUTLOOK RATING
1..100
42
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
9
SMR RATING
1..100
51
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLLGND
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
60%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 6 days ago
75%
Declines
ODDS (%)
Bearish Trend 14 days ago
82%
Bearish Trend 23 days ago
70%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
65%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signal:
Gain/Loss:
LGND
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MSTZ11.130.54
+5.10%
T-REX 2X Inverse MSTR Daily Target ETF
IDVO42.470.09
+0.21%
Amplify CWP International Enh Div IncETF
PLTI13.97N/A
N/A
REX PLTR Growth & Income ETF
EAOR37.87-0.07
-0.18%
iShares ESG Aware 60/40 Bal Allc ETF
MAYT38.85-0.13
-0.33%
AllianzIM US Equity Buffer10 May ETF

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with RXRX. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+3.80%
RXRX - ABCL
60%
Loosely correlated
-2.01%
CRSP - ABCL
56%
Loosely correlated
+0.50%
PRME - ABCL
56%
Loosely correlated
+4.33%
VCYT - ABCL
56%
Loosely correlated
-0.82%
ABSI - ABCL
54%
Loosely correlated
+13.50%
More

LGND and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGND has been loosely correlated with AXON. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if LGND jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGND
1D Price
Change %
LGND100%
-4.65%
AXON - LGND
49%
Loosely correlated
-3.16%
VCYT - LGND
41%
Loosely correlated
-0.82%
ABCL - LGND
37%
Loosely correlated
+3.80%
PCVX - LGND
37%
Loosely correlated
+1.30%
TVTX - LGND
36%
Loosely correlated
-0.07%
More